Incidentally, in our latest article in #FrontiersInGenetics we discuss the "Opportunities and challenges for newborn screening and early diagnosis of rare diseases in Latin America" including the opportunity to implement #GenomicSequencing as an add-on to current NBS programs to provide accurate diagnoses for patients living with #RareDiseases in #LATAM #GenomicEquity

https://www.frontiersin.org/articles/10.3389/fgene.2022.1053559/full

Proud to share our latest article on "Opportunities & Challenges for Newborn Screening and Early Diagnosis of Rare Diseases in Latin America" published today in #FrontiersInGenetics

This article is the product of careful review, deep discussion & insightful consensus on the current state and opportunities of newborn screening & early diagnosis approaches in Latin America for the better & accurate diagnosis of #RareDisease patients in #LATAM #ERCAL

https://www.frontiersin.org/articles/10.3389/fgene.2022.1053559/full

Brazilian study published in #FrontiersinGenetics show gender bias in the use of #menstrual blood. The material tends to be less used in experiments and its scientific value tends to be underestimated, which brings gender bias to a technical and molecular level. All this, despite proven scientific quality of menstrual blood mesenchymal cells. https://doi.org/10.3389/fgene.2022.957164